BPH Energy Limited, an Australian investment company listed on ASX, has a diverse portfolio that includes ventures in biotechnology, hydrogen innovation, and offshore gas exploration. The company holds a 16.3% stake in Clean Hydrogen Technologies Corporation, a U.S.-based company working on clean hydrogen production using unique catalysts and engineering systems. This aligns with the global shift towards low-emission fuel alternatives and battery manufacturing. Another significant holding is in Advent Energy Limited, which operates the PEP-11 permit in the Sydney Basin. Following application refusals by the Joint Authority, Asset Energy, a subsidiary of Advent Energy, has sought a judicial review, with a court hearing scheduled to challenge the decision. This legal action aims to maintain the permit's activity and regulatory compliance. Furthermore, BPH invests in Cortical Dynamics Limited, focusing on advanced brain monitoring systems for medical purposes. Their BARM™ device enhances anaesthetic care during surgeries, supported by the AI platform CORDYAN™ for real-time monitoring. Overall, BPH Energy's strategic investments in clean energy, offshore gas exploration, and healthcare technologies demonstrate a commitment to emerging sectors. The company's stock price on 13 May 2025 was AUD0.009, reflecting investor confidence in its diversified portfolio.